Upper Gastrointestinal Endoscopy and Gastrointestinal Biopsy — CPB 0738 | AETNA Coverage Update

Aetna modified CPB 0738 covering upper gastrointestinal endoscopy and GI biopsy, effective October 31, 2025. Here's what billing teams need to do.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0738 governing upper GI endoscopy and gastrointestinal biopsy coverage. This policy covers 150 CPT codes — including CPT 43235 (diagnostic EGD), CPT 43239 (EGD with biopsy), CPT 43259 (EGD with endoscopic ultrasound), and transnasal esophagoscopy codes 0652T through 0654T. If your practice bills for esophagoscopy, EGD, or endoscopic ultrasound procedures, this coverage policy change deserves your attention before October 31, 2025.

---

Quick Reference

Field	Detail
Payer	Aetna
Policy	Upper Gastrointestinal Endoscopy and Gastrointestinal Biopsy
Policy Code	CPB 0738
Change Type	Modified
Effective Date	October 31, 2025
Impact Level	High
Specialties Affected	Gastroenterology, General Surgery, Internal Medicine, Oncology
Key Action	Audit charge capture and documentation for all EGD and esophagoscopy claims before October 31, 2025

---

Aetna Upper GI Endoscopy Coverage Criteria and Medical Necessity Requirements 2025

The Aetna upper GI endoscopy coverage policy under CPB 0738 organizes medical necessity into two categories: high-risk screening EGD and diagnostic EGD. Each has specific clinical criteria that your documentation must support. Vague physician notes won't hold up on review.

High-Risk Screening EGD

Aetna covers screening EGD for medical necessity in three situations. First, patients with five or more years of chronic gastroesophageal reflux disease (GERD) who are at risk for Barrett's esophagus (BE). One critical detail: after a negative screening EGD, Aetna does not cover further screening EGDs. Document the prior negative result in your records — this is a common source of claim denial.

Second, patients with symptomatic pernicious anemia qualify. Aetna requires documented symptoms — anemia, fatigue, pallor, red tongue, shortness of breath, or tingling and numbness in the hands and feet. "Pernicious anemia" on the chart isn't enough. The symptoms need to be there.

Third, patients with cirrhosis and portal hypertension but no prior variceal hemorrhage qualify — particularly those with platelet counts below 140,000/mm³ or Child's class B or C disease. Your documentation needs to include the platelet count or the Child's classification.

Diagnostic EGD

The diagnostic EGD criteria under this coverage policy are broader, but each indication requires specific documentation. Aetna covers CPT 43235 and related codes when any of the following conditions are met:

Each of these indications links directly to covered CPT codes across the 43191–43278 range, as well as the transnasal endoscopy codes 43197, 43198, and 0652T–0654T. The medical necessity documentation you submit needs to match the specific indication — not just the code.

The real issue with this policy is the step-therapy requirements. For dyspepsia, Aetna expects documented evidence of H. pylori testing, treatment (if positive), and a failed PPI trial before EGD is covered. If your physicians are ordering EGDs without that paper trail, you'll see denials.

---

Aetna Upper GI Endoscopy Exclusions and Non-Covered Indications

This coverage policy is precise about what Aetna considers not medically necessary or experimental. These are common denial triggers — know them before you bill.

Screening EGD Repeat After Negative Result

After a negative screening EGD for Barrett's esophagus, further screening EGDs are not covered. This is a hard stop. If a patient has a negative EGD and the physician orders another screening procedure, Aetna will deny it. Document the prior negative result and ensure the new order is framed as diagnostic — not screening — if clinical circumstances warrant it.

Routine or Low-Risk Screenings

EGD as a general screening tool in low-risk, asymptomatic patients is not covered. The clinical criteria are specific. If the documentation doesn't map to one of the covered indications above, the claim will be denied.

PPI Trial Requirements Not Met

For dyspepsia in H. pylori-negative patients, Aetna requires documentation of an appropriate PPI trial — defined as 2–4 weeks of standard-dose once-daily PPI — before EGD is covered. For esophageal reflux symptoms, the threshold is an 8-week trial. Skipping the trial documentation is the single fastest path to a claim denial in this policy.

---

Coverage Indications at a Glance

---

Aetna Upper GI Endoscopy Billing Guidelines and Action Items 2025

Upper GI endoscopy billing under CPB 0738 rewards documentation discipline. Here's what your team needs to do before October 31, 2025.

Copy Action Items

If you're unsure how this policy applies to your patient mix — especially if you see high volumes of Barrett's screening or dyspepsia EGDs — loop in your compliance officer before the October 31 effective date.

---

CPT, HCPCS, and ICD-10 Codes for Upper GI Endoscopy Under CPB 0738

Covered CPT Codes (When Selection Criteria Are Met)

The policy data includes 70 additional CPT codes in this range. View the full code list at the CPB 0738 Aetna policy source.

ICD-10-CM Diagnosis Codes

CPB 0738 links 866 ICD-10-CM codes to this policy. The full list is available at the CPB 0738 Aetna policy source. Map your ICD-10-CM codes to the specific indication documented in the chart. A mismatch between the diagnosis code and the documented clinical indication is a fast path to prior authorization problems and claim denial.

---